jRCT2031230399已完成不适用
A Single and Multiple Dose Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetics of MK-1167 in Healthy Japanese Participants
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- MSD K.K.
- 入组人数
- 56
- 主要终点
- -
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized Controlled Trial
- 干预模型
- Parallel Assignment
- 主要目的
- Other
- 盲法
- Double Blind
入排标准
- 年龄范围
- 18age old over 至 45age old under（—）
- 性别
- All
入选标准
- •Healthy Japanese males or postmenopausal females aged 18 to 45 years old
排除标准
- •Has a history of clinically significant abnormalities or diseases
结局指标
主要结局
-
Safety
次要结局
- Evaluation of plasma pharmacokinetics
- Comparison of plasma pharmacokinetics among CYP2C19 phenotypes
研究者
相似试验
已完成
不适用
A study of the effects of single doses of MK-1167 on neurotransmitter cycling in the brain of healthy adult participants using 13C-Magnetic Resonance Spectroscopy.10012272Alzheimer's DementiaNL-OMON51348Merck Sharp & Dohme LLC, a subsidiary of Merck & Co. Inc.48
已完成
不适用
Single and Multiple Dose Study of MK-7480 in Healthy Japanese ParticipantsNonalcoholic fatty liver diseasejRCT2071240015MSD K.K.36
进行中（未招募）
不适用
Single and Multiple Dose Study of MK-1708 in Healthy Japanese ParticipantsjRCT2071240035MSD K.K.64
已完成
1 期
A Multiple-Ascending-Dose Study of MK-1708 in Healthy Participants2024-511405-27-00Merck Sharp & Dohme LLC32
招募中
不适用
Phase 2 Study of MK-1167 in Participants with Mild to Moderate Alzheimer's Disease DementiajRCT2031240682MSD K.K.350